journal article·2025-10Open access

Intelligent transdermal nanoparticles as synergizing advanced delivery systems for precision therapeutics

Zhouying Guo, Yi'nan Zhang, Man Zhao, Wenyuan Zhang, Xiaofang Li, Fang Zhou, Haisheng Peng, Qun Wang, Zhiwei Chen

Abstract

Transdermal drug delivery systems (TDDS) represent a non-invasive approach to achieve controlled drug release through the skin barrier, offering stable plasma concentrations while avoiding gastrointestinal and hepatic metabolism. However, the skin barrier poses physical challenges, making it difficult for most drugs to penetrate deep tissues using TDDS. This review systematically summarizes the research progress in nanocarrier design, physical technology application, and artificial intelligence (AI)-driven TDDS optimization design aimed at overcoming the key problem of skin barrier penetration. An in-depth analysis of nanocarriers, such as soft vesicles, nanoemulsions, rigid nanoparticles, and physically assisted enhancement technologies, and AI-driven research on skin penetration enhancement in TDDS was summarized. An integrated technical framework demonstrates how microneedle arrays, iontophoresis, electroporation, and photoporation synergize with nanoparticles to achieve spatiotemporally controlled transdermal drug delivery. Additionally, the review emphasizes the clinical application potential of these integrated technologies and offers a comprehensive, multidimensional perspective to advance innovation in TDDS.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Dermatology and Skin Diseases · Acne and Rosacea Treatments and Effects

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Long-acting parenteral drug delivery systems for the treatment of chronic diseases10.1016/j.addr.2023.114862 ↗
2. Medicine use in chronic diseases10.3390/pharmacy11030100 ↗
3. Medication routes of administration
4. Aflatoxins in foods and feeds: a review on health implications, detection, and control
5. Recent advancement on TDDS (transdermal drug delivery system)10.55544/jrasb.1.5.6 ↗
6. Long-acting transdermal drug delivery formulations: current developments and innovative pharmaceutical approaches
7. Optimization of lipid nanoparticles for gene editing of the liver via intraduodenal delivery
8. Carrier-free immunotherapeutic nano-booster with dual synergistic effects based on glutaminase inhibition combined with photodynamic therapy10.1021/acsnano.2c11037 ↗
9. Self-assembly nanoplatform of platinum (IV) prodrug for enhanced ovarian cancer therapy
10. Luminescence-activated Pt(IV) prodrug for in situ triggerable cancer therapy10.1016/j.cclet.2023.109134 ↗
11. COX-2 blocking therapy in cisplatin chemosensitization of ovarian cancer: an allicin-based nanomedicine approach10.1016/j.cclet.2023.109241 ↗
12. Skin patch drug delivery
13. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain10.2165/00002018-200326130-00004 ↗
14. Topic-the scenario of pharmaceuticals and development of microwave as; sisted extraction technique
15. Transdermal delivery of drugs with microneedles-potential and challenges10.3390/pharmaceutics7030090 ↗
16. Transdermal drug delivery10.1007/978-3-642-00477-3_13 ↗
17. Recent updates on transdermal drug delivery approaches for the management of gout and its clinical perspective10.2174/1389201024666230606143827 ↗
18. A snapshot of transdermal and topical drug delivery research in Canada10.3390/pharmaceutics11060256 ↗
19. Transdermal delivery systems for biomolecules10.1007/s12247-020-09525-2 ↗
20. Ali
21. Transdermal and topical drug administration in the treatment of pain10.3390/molecules23030681 ↗
22. Recent approaches in transdermal drug delivery system10.5958/0974-360X.2019.00783.2 ↗
23. Predicting skin permeability using HuskinDB10.1038/s41597-022-01698-4 ↗
24. The 500 dalton rule for the skin penetration of chemical compounds and drugs10.1034/j.1600-0625.2000.009003165.x ↗
25. An examination of published datasets of skin permeability and partition coefficients10.1016/j.tiv.2023.105702 ↗
26. Physico-chemical determinants of dermal drug delivery: effects of the number and substitution pattern of polar groups10.1016/S0928-0987(02)00085-4 ↗
27. Functional nano-systems for transdermal drug delivery and skin therapy10.1039/D2NA00530A ↗
28. Nanostructured lipid carriers as potential drug delivery systems for skin disorders10.2174/1381612826666200614175236 ↗
29. Perspectives of lipid-based drug carrier systems for transdermal delivery10.1615/CritRevTherDrugCarrierSyst.2018020856 ↗
30. Exploiting solid lipid nanoparticles and nanostructured lipid carriers for drug delivery against cutaneous fungal infections10.1080/1040841X.2020.1843399 ↗
31. Lipid-based nanosystems as a tool to overcome skin barrier10.3390/ijms22158319 ↗
32. Nanocarrier-based topical drug delivery for the treatment of skin diseases10.1517/17425247.2012.686490 ↗
33. Delivering the power of nanomedicine to patients today10.1016/j.jconrel.2020.07.007 ↗
34. Current research trends of nanomedicines10.1016/j.apsb.2023.05.018 ↗
35. Advance and challenges in the treatment of skin diseases with the transdermal drug delivery system10.3390/pharmaceutics15082165 ↗
36. Ethosomes as nanocarriers for the development of skin delivery formulations10.1007/s11095-021-03053-5 ↗
37. Ethosomes and lipid-coated chitosan nanocarriers for skin delivery of a chlorophyll derivative: a potential treatment of squamous cell carcinoma by photodynamic therapy10.1016/j.ijpharm.2019.118528 ↗
38. Nanoparticles for topical drug delivery: potential for skin cancer treatment10.1016/j.addr.2020.05.011 ↗
39. Nanotechnological breakthroughs in the development of topical phytocompounds-based formulations10.1016/j.ijpharm.2019.118787 ↗
40. Liposomes and transferosomes: a breakthrough in topical and transdermal delivery10.4155/tde-2020-0122 ↗
41. Enhanced transdermal efficiency of curcumin-loaded peptide-modified liposomes for highly effective antipsoriatic therapy10.1039/D1TB00557J ↗
42. Ex vivo evaluation of ethosomes and transethosomes applied on human skin: a comparative study10.3390/ijms232315112 ↗
43. Mechanism investigation of ethosomes transdermal permeation
44. Unlocking the potential of cosmetic dermal delivery with ethosomes: a comprehensive review10.1111/jocd.15895 ↗
45. Role of nanotechnology in cosmeceuticals: a review of recent advances10.1155/2018/3420204 ↗
46. Niosome as a promising tool for increasing the effectiveness of anti-inflammatory compounds
47. Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications10.1016/j.ejpb.2019.08.015 ↗
48. Evaluations of quality by design (QbD) elements impact for developing niosomes as a promising topical drug delivery platform10.3390/pharmaceutics12030246 ↗
49. Novel herbal drug delivery system: an overview10.4103/amhs.amhs_88_17 ↗
50. Phospholipid vesicles for dermal/transdermal and nasal administration of active molecules: the effect of surfactants and alcohols on the fluidity of their lipid bilayers and penetration enhancement properties10.3390/molecules25132959 ↗
51. Identifying underlying issues related to the inactive excipients of transfersomes based drug delivery system10.2174/1381612826666201016144354 ↗
52. Deferoxamine-loaded transfersomes accelerates healing of pressure ulcers in streptozotocin-induced diabetic rats
53. Polymeric micelles as cutaneous drug delivery system in normal skin and dermatological disorders
54. A multifunctional herb-derived glycopeptide hydrogel for chronic wound healing
55. Physical enhancement? Nanocarrier? Current progress in transdermal drug delivery10.3390/nano11020335 ↗
56. Stabilization of bicelles using metal-binding peptide for extended blood circulation10.1039/D2CC01058E ↗
57. Change in morphology of dimyristoylphosphatidylcholine/bile salt derivative bicelle assemblies with dodecylmaltoside in the disk and ribbon phases10.1021/acs.jpclett.2c02445 ↗
58. Solid lipid nanoparticles: emerging colloidal nano drug delivery systems10.3390/pharmaceutics10040191 ↗
59. TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy10.1016/j.jconrel.2021.08.039 ↗
60. Polymeric nanocarriers of drug delivery systems in cancer therapy10.3390/pharmaceutics12040298 ↗
61. Synchrotron-based infrared microspectroscopy of polymeric nanoparticles and skin: unveiling molecular interactions to enhance permeation10.1016/j.chemphyslip.2022.105254 ↗
62. Gold nanoparticles for skin drug delivery10.1016/j.ijpharm.2022.122122 ↗
63. Skin absorption of inorganic nanoparticles and their toxicity: a review10.1016/j.ejpb.2022.12.010 ↗
64. Recent progress in transdermal nanocarriers and their surface modifications10.3390/molecules26113093 ↗
65. Gold nanoparticles and their applications in transdermal drug delivery: a review
66. Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis10.2147/IJN.S165966 ↗
67. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications10.1016/j.jconrel.2017.11.049 ↗
68. Microemulsions and nanoemulsions in skin drug delivery10.3390/bioengineering9040158 ↗
69. Topical delivery of nanoemulsions for skin cancer treatment
70. A recent overview on dermatological applications of liposomes10.2174/1872210514666201021145233 ↗
71. Can drug-bearing liposomes penetrate intact skin?10.1211/jpp.58.4.0001 ↗
72. Codelivery of benzoyl peroxide & adapalene using modified liposomal gel for improved acne therapy10.2217/nnm-2018-0002 ↗
73. Current advances in lipid nanosystems intended for topical and transdermal drug delivery applications10.3390/pharmaceutics15020656 ↗
74. Nanocarrier-based transdermal drug delivery systems for dermatological therapy10.3390/pharmaceutics16111384 ↗
75. High molecular weight hyaluronic acid-liposome delivery system for efficient transdermal treatment of acute and chronic skin photodamage10.1016/j.actbio.2024.05.026 ↗
76. Development and application of novel peptide-formulated nanoparticles for treatment of atopic dermatitis10.1039/D3TB01202F ↗
77. High-throughput microfluidic production of ultrasmall lecithin nanoliposomes for high-efficacy transdermal delivery and skin-aging treatment10.3390/biomedicines13020322 ↗
78. Hyperbranched macromonomer-based gelation of hyaluronic acid for efficient liposome encapsulation and improved transdermal delivery10.1002/marc.202500310 ↗
79. Co-encapsulated Ce6 + CpG and biopeptide-modified liposomes for enhanced transdermal photo-immunotherapy of superficial tumors
80. Berberine hydrochloride-loaded liposomes-in-hydrogel microneedles achieve the efficient treatment for psoriasis
81. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers10.1016/j.jconrel.2005.04.007 ↗
82. Liposomes with an ethanol fraction as an application for drug delivery10.3390/ijms19123806 ↗
83. Treatment of basal cell carcinoma via binary ethosomes of vismodegib: in vitro and in vivo studies10.1208/s12249-019-1574-x ↗
84. Thymoquinone-loaded ethosome with breast cancer potential: optimization, in vitro and biological assessment10.1007/s40097-019-00325-w ↗
85. Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo10.2147/IJN.S16044 ↗
86. Ethosomes as dermal/transdermal drug delivery systems: applications, preparation and characterization10.1080/08982104.2022.2085742 ↗
87. Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib10.3109/10717544.2012.724472 ↗
88. Ethosomes: transdermal drug delivery system10.22270/jddt.v9i3.2692 ↗
89. Gossypin-loaded ethosome gel for cutaneous administration: a preliminary study on melanoma cells10.3390/antiox14020186 ↗
90. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier10.1016/j.jconrel.2003.10.014 ↗
91. Ibuprofen transdermal ethosomal gel: characterization and efficiency in animal models10.1166/jbn.2010.1153 ↗
92. Formulation and evaluation of curcumin loaded ethosomes as novel drug delivery system
93. Preparation of ethosome gel with total flavonoids from Vernonia anthelmintica (L.) willd. For the treatment of vitiligo10.3390/gels11010073 ↗
94. Transdermal insulin delivery using ionic liquid-mediated nanovesicles for diabetes treatment10.1021/acsbiomaterials.4c02000 ↗
95. Comparative study of liposomal and ethosomal formulations of Curcuma heyneana rhizome extract in a transdermal delivery system10.2174/0122117385252518231018161755 ↗
96. Physicochemical properties and skin permeation of span 60/Tween 60 niosomes of ellagic acid10.1016/j.ijpharm.2011.11.032 ↗
97. Vesicular carriers for skin drug delivery: the pheroid™ technology10.2174/1381612821666150428125812 ↗
98. Loading of water-insoluble celastrol into niosome hydrogels for improved topical permeation and anti-psoriasis activity10.1016/j.colsurfb.2019.110352 ↗
99. Development of tizanidine loaded aspasomes as transdermal delivery system: ex-vivo and in-vivo evaluation10.1080/08982104.2019.1684940 ↗
100. Niosomes gel of apigenin to improve the topical delivery: development, optimization, ex vivo permeation, antioxidant study, and in vivo evaluation10.1080/21691401.2023.2274526 ↗